BeStock  
Markets › Compare › ARWR vs ADDHY

ARWR vs ADDHY

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ARWR · Arrowhead Pharmaceuticals$62.35 ▼ 2.87%
ADDHY · ADDTECH AB UNSPON ADS EACH REP 0.5 ORD SHS$16.81 ▼ 1.98%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

84127169212254Oct 7, '25Apr 7, '26Oct 5, '26
  • ARWR +70.6%
  • ADDHY +4.6%

Head to head

MetricARWRADDHY
Price$62.35$16.81
Change today▼ 2.87%▼ 1.98%
Market cap$8.81B$8.80B
Return, 3 months-28.3%-2.4%
Return, year to date-6.1%-4.7%
Return, 1 year+66.3%-0.9%
P/E (TTM)-27.338.2
P/B18.90.7
P/E percentile vs own 5y––
Dividend yield–1.15%
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)2847
30-day volatility56.0%31.1%
Max drawdown, 1 year-30.4%-19.7%
Trend readStrong downtrendLeaning bearish
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ARWR is the largest of the group by market value.
  • ARWR has returned the most over the past year.
  • ARWR carries the lowest trailing P/E.
  • ADDHY has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top